Elsevier

Biomaterials

Volume 33, Issue 13, May 2012, Pages 3539-3547
Biomaterials

Biologic scaffolds composed of central nervous system extracellular matrix

https://doi.org/10.1016/j.biomaterials.2012.01.044Get rights and content

Abstract

Acellular biologic scaffolds are commonly used to facilitate the constructive remodeling of three of the four traditional tissue types: connective, epithelial, and muscle tissues. However, the application of extracellular matrix (ECM) scaffolds to neural tissue has been limited, particularly in the central nervous system (CNS) where intrinsic regenerative potential is low. The ability of decellularized liver, lung, muscle, and other tissues to support tissue-specific cell phenotype and function suggests that CNS-derived biologic scaffolds may help to overcome barriers to mammalian CNS repair. A method was developed to create CNS ECM scaffolds from porcine optic nerve, spinal cord, and brain, with decellularization verified against established criteria. CNS ECM scaffolds retained neurosupportive proteins and growth factors and, when tested with the PC12 cell line in vitro, were cytocompatible and stimulated proliferation, migration, and differentiation. Urinary bladder ECM (a non-CNS ECM scaffold) was also cytocompatible and stimulated PC12 proliferation but inhibited migration rather than acting as a chemoattractant over the same concentration range while inducing greater rates of PC12 differentiation compared to CNS ECM. These results suggest that CNS ECM may provide tissue-specific advantages in CNS regenerative medicine applications and that ECM scaffolds in general may aid functional recovery after CNS injury.

Introduction

The extracellular matrix (ECM) represents the secreted product of the resident cells of each tissue and organ and thus logically defines the ideal substrate or scaffold for maintenance of tissue-specific cell phenotype. The ECM is a critical determinant of cell behavior and is known to affect intracellular signaling pathways, cell differentiation events, and cell proliferation among other important characteristics of tissue identity [1], [2], [3], [4], [5], [6], [7], [8]. These events are mediated through integrins and other cell surface receptors in response to ligands present within the ECM of every tissue [9], [10], [11]. Subtle changes in ECM structure and mechanical properties can affect cell transcriptional events and associated cell phenotype and function [12], [13].

Biologic scaffolds composed of ECM have been commonly used for the therapeutic reconstruction of many tissues including myocardium [14], [15], [16], kidney [17], lower urinary tract [18], [19], musculotendinous tissues [20], [21], [22], esophagus [23], and peripheral nerve [24], among others. There is clinical precedent for the application of ECM scaffolds in reconstruction of central nervous system (CNS) structures [25], [26], but the development of ECM scaffolds for CNS regenerative medicine strategies has received relatively scarce attention [27], [28], [29]. It has been suggested that ECM harvested from specific tissues is the preferred substrate for cells native to those respective tissues if maintenance of phenotypic characteristics is important [3], [4], [5], [6], [7], [8], [30]. The methods by which ECM scaffolds are prepared vary greatly and such methods can markedly affect the composition, architecture, and material properties of the resulting construct [31], [32], [33], [34] as well as the host response following implantation [35], [36], [37], [38]. Therefore, the methods of preparing ECM scaffolds intended for use in the repair and reconstruction of complex vital tissues such as heart, liver, kidney, and the CNS must be carefully considered as regenerative medicine strategies are developed for these tissues and organs.

The objectives of the present study were to (1) develop a method for decellularization of a variety of CNS tissues, (2) characterize the resulting CNS ECM scaffolds in terms of composition and in vitro cytocompatibility, and (3) investigate potential tissue-specific advantages of CNS ECM scaffolds compared to non-CNS ECM scaffolds by evaluating in vitro modulation of PC12 cell line mitogenesis, chemotaxis, and differentiation.

Section snippets

Preparation of CNS ECM

Porcine optic nerve, spinal cord, and brain tissues were obtained from animals (∼120 kg) at a local abattoir (Thoma's Meat Market, Saxonburg, PA). Tissues were frozen (>16 h at −80 °C), thawed completely, and separated from all non-CNS tissue. Dura mater was removed, and optic nerve and spinal cord tissues were longitudinally quartered and cut into lengths (<3 cm). The decellularization process consisted of a series of agitated baths: water (type I reagent water per ASTM D1193; 16 h at 4 °C;

Efficacy of decellularization method

No residual nuclei were visible in H&E and DAPI images of ECM derived from optic nerve, spinal cord, or brain (Fig. 2A–M). Maximum fragment size of residual DNA in CNS ECM scaffolds did not exceed 200 bp (Fig. 2N) [31]. Quantification of dsDNA using PicoGreen showed that CNS ECM scaffolds retained <50 ng dsDNA per mg dry ECM (Fig. 2P–R). Concentrations of dsDNA were 44.6 ± 7.9 ng/mg in optic nerve ECM, 37.9 ± 7.7 ng/mg in spinal cord ECM, and 40.2 ± 3.8 ng/mg in brain ECM.

CNS ECM constituents

Histologic staining

Discussion

This study describes a versatile decellularization method which can be applied to three different CNS tissues: optic nerve, spinal cord, and brain (Fig. 1). The full protocol from tissue to ECM requires <24 h, a duration which compares favorably to previously reported CNS tissue decellularization methods [27], [28], [29]. The resulting matrix is sufficiently acellular (Fig. 2) to obviate adverse host immune responses [35], [36], [37], [38] and contagion such as virus transmission [47], [48],

Conclusion

A variety of acellular biologic scaffolds can be derived from CNS tissues such as optic nerve, spinal cord, and brain by a combination of enzymatic and chemical processing (Fig. 1, Fig. 2). These CNS ECM scaffolds meet or exceed established decellularization criteria [31], are cytocompatible (Fig. 5), and retain neurosupportive proteins and growth factors present within the tissues of origin (Fig. 3, Fig. 4) which are known to modify neural cell behaviors. The resultant acellular biologic

Acknowledgments

This work was supported in part by the NIH (5R01AR053603), an Ocular Tissue Engineering and Regenerative Ophthalmology (OTERO) Fellowship from the Louis J. Fox Center for Vision Restoration (a joint program of UPMC and the University of Pittsburgh), and an NIBIB training grant (T32EB001026). The authors also thank Deanna Rhoads for histologic sectioning and Chris Carruthers for experimental assistance.

References (58)

  • P.M. Crapo et al.

    An overview of tissue and whole organ decellularization processes

    Biomaterials

    (2011)
  • T.J. Keane et al.

    Consequences of ineffective decellularization of biologic scaffolds on the host response

    Biomaterials

    (2012)
  • B.N. Brown et al.

    Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular component

    Biomaterials

    (2009)
  • K.J. Ishii et al.

    Innate immune recognition of, and regulation by, DNA

    Trends Immunol

    (2006)
  • T.W. Gilbert et al.

    Quantification of DNA in biologic scaffold materials

    J Surg Res

    (2009)
  • J.E. Reing et al.

    The effects of processing methods upon mechanical and biologic properties of porcine dermal extracellular matrix scaffolds

    Biomaterials

    (2010)
  • F.L. Hall et al.

    Suppression of nerve growth factor-directed neurite outgrowth in PC12 cells by sphingosine, an inhibitor of protein kinase C

    J Biol Chem

    (1988)
  • F.A. Mendes et al.

    Concentration-dependent actions of glial chondroitin sulfate on the neuritic growth of midbrain neurons

    Brain Res Dev Brain Res

    (2003)
  • D.O. Freytes et al.

    Preparation and rheological characterization of a gel form of the porcine urinary bladder matrix

    Biomaterials

    (2008)
  • Y. Hong et al.

    Mechanical properties and in vivo behavior of a biodegradable synthetic polymer microfiber-extracellular matrix hydrogel biohybrid scaffold

    Biomaterials

    (2011)
  • J. Cortiella et al.

    Influence of acellular natural lung matrix on murine embryonic stem cell differentiation and tissue formation

    Tissue Eng Part A

    (2010)
  • H.C. Ott et al.

    Regeneration and orthotopic transplantation of a bioartificial lung

    Nat Med

    (2010)
  • T.L. Sellaro et al.

    Maintenance of hepatic sinusoidal endothelial cell phenotype in vitro using organ-specific extracellular matrix scaffolds

    Tissue Eng

    (2007)
  • P. Lin et al.

    Assessing porcine liver-derived biomatrix for hepatic tissue engineering

    Tissue Eng

    (2004)
  • M.S. Wicha et al.

    Extracellular matrix promotes mammary epithelial growth and differentiation in vitro

    Proc Natl Acad Sci U S A

    (1982)
  • C.M. Nelson et al.

    Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer

    Annu Rev Cell Dev Biol

    (2006)
  • P. Gassmann et al.

    Role of tumor cell adhesion and migration in organ-specific metastasis formation

    Onkologie

    (2004)
  • D. Bonneh-Barkay et al.

    Brain extracellular matrix in neurodegeneration

    Brain Pathol

    (2009)
  • J.M. Wainwright et al.

    Right ventricular outflow tract repair with a cardiac biologic scaffold

    Cells Tissues Organs

    (2012)
  • Cited by (211)

    • Decellularized matrix for repairing intervertebral disc degeneration: Fabrication methods, applications and animal models

      2023, Materials Today Bio
      Citation Excerpt :

      However, these materials showed limited use in IDD therapy since they possessed limited physical and mechanical properties intrinsic to the IVD owing to the lack of crucial functional factors replicating the IVD's native microenvironment [1]. For example, artificially synthesized AF could not confirm the NP region and could not sufficiently overcome the tensile loads [1], whereas NP scaffolds could not provide a gradual change in mechanical strength, similar to that by natural NP tissues [54–56]. Although DWJM [43], the pericardium [40], and SIS [46], being neoteric decellularization materials, were demonstrated to be promising agents for IDD repair, further validation is needed.

    View all citing articles on Scopus
    1

    These authors contributed equally to this work.

    View full text